Bernstein Liebhard LLP announced that a shareholder has filed a securities class action lawsuit on behalf of investors who purchased or acquired Capricor Therapeutics, Inc. securities between December 17, 2025 and July 6, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the company's business operations, growth prospects, and financial stability, causing Capricor securities to trade at artificially inflated prices. Investors who suffered large losses are encouraged to contact the firm before the September 28, 2026 lead plaintiff deadline. Bernstein Liebhard has recovered over $3.5 billion for clients since 1993.
Capricor Therapeutics IncSecurities class action lawsuit alleges false statements, causing artificial inflation of stock price.